Citations
Citations to this article as recorded by
- Hypecotumines A-D, new isoquinoline alkaloids with potential PCSK9 inhibition activity from Hypecoum erectum L.
Yinling Wei, Hongyan Wen, Lian Yang, Bodou Zhang, Xiaoyu Li, Sheng Li, Jing Dong, Zhenzhen Liang, Yu Zhang
Natural Products and Bioprospecting.2024;[Epub] CrossRef - Application of PCSK9 Inhibitors in Lipid Metabolism and Arteriosclerosis
扬 刘
Advances in Clinical Medicine.2023; 13(08): 12430. CrossRef - Bempedoic acid a novel drug used for the treatment of Hyperlipidaemia: A Review
Rahul D. Shimpi, Shashikant D. Barhate, Mayur S. Jain
Asian Journal of Pharmaceutical Research.2023; : 68. CrossRef - Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
Gyuri Kim, Suk-Yong Jang, Chung Mo Nam, Eun Seok Kang
Journal of Hepatology.2018; 68(3): 476. CrossRef - Change in ALT levels after administration of HMG‐CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
Hyunah Kim, Hyeseon Lee, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun‐Ho Yoon, Hun‐Sung Kim
Cardiovascular Therapeutics.2018;[Epub] CrossRef - Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
Jingyun Choi, Yejin Kim, Hun-Sung Kim, In Young Choi, Hwanjo Yu, Katriina Aalto-Setala
PLOS ONE.2018; 13(6): e0197518. CrossRef - Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Endocrinology and Metabolism.2017; 32(2): 274. CrossRef - Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study
Gyuri Kim, Suk‐Yong Jang, Eugene Han, Yong‐ho Lee, Se‐young Park, Chung Mo Nam, Eun Seok Kang
International Journal of Cancer.2017; 140(4): 798. CrossRef - PCSK9 as a therapeutic target for cardiovascular disease
Pei-Ying Zhang
Experimental and Therapeutic Medicine.2017; 13(3): 810. CrossRef - Use of Moderate‐Intensity Statins for Low‐Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans
Hun‐Sung Kim, Hyeseon Lee, Sue Hyun Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Hyunah Kim, Seung‐Hwan Lee, Jae Hyoung Cho, In‐Young Choi, Kun‐Ho Yoon, Ju Han Kim
Basic & Clinical Pharmacology & Toxicology.2017; 121(4): 272. CrossRef - Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes
Ekaterina A. Ivanova, Alexander N. Orekhov, Agnes L. Nishimura
Stem Cells International.2016;[Epub] CrossRef - PCSK9 inhibitors in the prevention of cardiovascular disease
James Latimer, Jonathan A. Batty, R. Dermot G. Neely, Vijay Kunadian
Journal of Thrombosis and Thrombolysis.2016; 42(3): 405. CrossRef - Analysis and comparison of statin prescription patterns and outcomes according to clinical department
H.-S. Kim, H. Kim, H. Lee, B. Park, S. Park, S.-H. Lee, J. H. Cho, H. Song, J. H. Kim, K.-H. Yoon, I. Y. Choi
Journal of Clinical Pharmacy and Therapeutics.2016; 41(1): 70. CrossRef - Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
H.‐S. Kim, S. H. Lee, H. Kim, S.‐H. Lee, J. H. Cho, H. Lee, H. W. Yim, S.‐H. Kim, I.‐Y. Choi, K.‐H. Yoon, J. H. Kim
Journal of Clinical Pharmacy and Therapeutics.2016; 41(3): 266. CrossRef - New Drugs for Treating Dyslipidemia: Beyond Statins
Chang Ho Ahn, Sung Hee Choi
Diabetes & Metabolism Journal.2015; 39(2): 87. CrossRef - Pharmacological treatment and therapeutic perspectives of metabolic syndrome
Soo Lim, Robert H. Eckel
Reviews in Endocrine and Metabolic Disorders.2014; 15(4): 329. CrossRef